Pezzella F, Ralfkiaer E, Gatter K C, Mason D Y
Nuffield Department of Pathology, John Radcliffe Hospital, Oxford.
Br J Haematol. 1990 Sep;76(1):58-64. doi: 10.1111/j.1365-2141.1990.tb07836.x.
The 14;18 chromosomal translocation is widely recognized as a cytogenetic abnormality associated with follicular lymphomas, but estimates of its frequency in this type of lymphoma vary widely from less than 50% to almost 90%. Furthermore, no extensive data have been published on the frequency of t(14;18) in European cases of follicular lymphoma. Lymph nodes from 51 patients with follicular lymphomas obtained from two European centres (Oxford and Copenhagen) were examined for the presence of this translocation. Southern blotting and the polymerase chain reaction (PCR) were used in 26 cases and the PCR alone in 25 cases (from which only degraded DNA or formalin fixed samples were available). DNA probes capable of detecting rearrangement at both the major and the minor breakpoint regions were employed. We could detect t(14;18) in only 21 out of 51 cases (41%). However, a review of the literature showed that comparable results have been obtained previously using both cytogenetic and molecular biological techniques and our results support the view that the global incidence of t(14;18) in follicular lymphoma is no greater than 70%. Furthermore, this study has indicated that the PCR is a reliable method for identifying t(14;18) when only formalin-fixed paraffin-embedded tissue or degraded DNA is available.
14;18染色体易位被广泛认为是与滤泡性淋巴瘤相关的一种细胞遗传学异常,但在这类淋巴瘤中其出现频率的估计差异很大,从不到50%到近90%不等。此外,关于欧洲滤泡性淋巴瘤病例中t(14;18)频率的广泛数据尚未发表。对来自两个欧洲中心(牛津和哥本哈根)的51例滤泡性淋巴瘤患者的淋巴结进行了该易位的检测。26例使用了Southern印迹法和聚合酶链反应(PCR),25例仅使用了PCR(这些病例仅有降解的DNA或福尔马林固定样本)。使用了能够检测主要和次要断点区域重排的DNA探针。在51例病例中,我们仅在21例(41%)中检测到了t(14;18)。然而,文献回顾显示,此前使用细胞遗传学和分子生物学技术都得到了类似结果,我们的结果支持这样一种观点,即滤泡性淋巴瘤中t(14;18)的全球发生率不超过70%。此外,本研究表明,当仅有福尔马林固定石蜡包埋组织或降解DNA时,PCR是鉴定t(14;18)的可靠方法。